Clinical Trial Update: Bryostatin 1 in Treating Patients With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Bryostatin 1 for stage IV breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED